Hemangioma Clinical Trial
Official title:
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
There is no effective treatment for hemangioma regardless of immediate severity. That is in this respect a orphan disease. These hemangiomas, sometimes large, will have a phase of proliferation of several months (very scary for parents) and regression over several years. The natural history is peppered with local complications (ulcers) and aesthetic and psychological sequelae (sometimes major for the child and the family). The effects of acebutolol and propranolol on the proliferative hemangiomas were discovered accidentally by two French teams (Montpellier for acebutolol and Bordeaux for propranolol). Acebutolol and propranolol have been used for many years for the treatment of hypertension and congenital heart disease, including infants, with few side effects. The effects of acebutolol and propranolol were immediately visible with reduced volume and skin whitening of the hemangioma. In a preliminary study, acebutolol was administered to 20 patients in Montpellier with big regression of hemangiomas. The aim of the study was to compare the clinical efficacy of acebutolol (10mg/Kg/jour) and propranolol (3mg/Kg/j) on the proliferative phase of infantile hemangioma in infants.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01685398 -
Topical Timolol for Superficial Infantile Hemangioma
|
Phase 3 | |
| Withdrawn |
NCT00974129 -
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
|
N/A | |
| Completed |
NCT00374335 -
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
|
N/A | |
| Recruiting |
NCT03331744 -
Clinical Characteristics of Infantile Hemangioma
|
||
| Completed |
NCT02342275 -
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
|
Phase 3 | |
| Completed |
NCT00433940 -
Immune Suppression Of Infants Treated With Steroids
|
N/A | |
| Completed |
NCT04065217 -
The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial
|
N/A | |
| Terminated |
NCT00555464 -
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
|
Phase 2 | |
| Completed |
NCT00394888 -
Hemangioma Associated With High Rates of Morbidity
|
N/A | |
| Completed |
NCT05327309 -
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
|
N/A | |
| Completed |
NCT02145884 -
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
|
Phase 2 | |
| Completed |
NCT04077515 -
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
|
Phase 4 | |
| Completed |
NCT02731287 -
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
|
Phase 2 | |
| Recruiting |
NCT01147601 -
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
|
Phase 0 | |
| Completed |
NCT01908972 -
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
|
Phase 4 | |
| Completed |
NCT00540566 -
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
|
||
| Completed |
NCT00001417 -
Direct Injection of Alcohol for the Treatment of Spinal Tumors
|
N/A | |
| Completed |
NCT00004436 -
Randomized Study of Hormonal Regulation of Infantile Hemangioma
|
N/A | |
| Recruiting |
NCT02496013 -
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
|
Phase 1 | |
| Completed |
NCT01072045 -
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
|
Phase 2 |